Copyright Reports & Markets. All rights reserved.

Global Endocrine Peptides Test Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Endocrine Peptides Test Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Endocrine Peptides Test Market Size Growth Rate by Product
      • 1.4.2 Estradiol (E2)
      • 1.4.3 Dehydroepiandrosterone Sulfate (DHEAS)
      • 1.4.4 Human Chorionic Gonadotropin (hCG)
      • 1.4.5 Progesterone, Luteinizing Hormone (LH)
      • 1.4.6 Thyroid Stimulating Hormone (TSH)
      • 1.4.7 Thyroid Prolactin
      • 1.4.8 Others
    • 1.5 Market by End User
      • 1.5.1 Global Endocrine Peptides Test Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Physicians’ offices
      • 1.5.4 Commercial Laboratories
      • 1.5.5 Health Care Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Endocrine Peptides Test Market Size
      • 2.1.1 Global Endocrine Peptides Test Revenue 2014-2025
      • 2.1.2 Global Endocrine Peptides Test Sales 2014-2025
    • 2.2 Endocrine Peptides Test Growth Rate by Regions
      • 2.2.1 Global Endocrine Peptides Test Sales by Regions
      • 2.2.2 Global Endocrine Peptides Test Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Endocrine Peptides Test Sales by Manufacturers
      • 3.1.1 Endocrine Peptides Test Sales by Manufacturers
      • 3.1.2 Endocrine Peptides Test Sales Market Share by Manufacturers
      • 3.1.3 Global Endocrine Peptides Test Market Concentration Ratio (CR5 and HHI)
    • 3.2 Endocrine Peptides Test Revenue by Manufacturers
      • 3.2.1 Endocrine Peptides Test Revenue by Manufacturers (2014-2019)
      • 3.2.2 Endocrine Peptides Test Revenue Share by Manufacturers (2014-2019)
    • 3.3 Endocrine Peptides Test Price by Manufacturers
    • 3.4 Endocrine Peptides Test Manufacturing Base Distribution, Product Types
      • 3.4.1 Endocrine Peptides Test Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Endocrine Peptides Test Product Type
      • 3.4.3 Date of International Manufacturers Enter into Endocrine Peptides Test Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Endocrine Peptides Test Sales by Product
    • 4.2 Global Endocrine Peptides Test Revenue by Product
    • 4.3 Endocrine Peptides Test Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Endocrine Peptides Test Breakdown Data by End User

    6 North America

    • 6.1 North America Endocrine Peptides Test by Countries
      • 6.1.1 North America Endocrine Peptides Test Sales by Countries
      • 6.1.2 North America Endocrine Peptides Test Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Endocrine Peptides Test by Product
    • 6.3 North America Endocrine Peptides Test by End User

    7 Europe

    • 7.1 Europe Endocrine Peptides Test by Countries
      • 7.1.1 Europe Endocrine Peptides Test Sales by Countries
      • 7.1.2 Europe Endocrine Peptides Test Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Endocrine Peptides Test by Product
    • 7.3 Europe Endocrine Peptides Test by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Endocrine Peptides Test by Countries
      • 8.1.1 Asia Pacific Endocrine Peptides Test Sales by Countries
      • 8.1.2 Asia Pacific Endocrine Peptides Test Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Endocrine Peptides Test by Product
    • 8.3 Asia Pacific Endocrine Peptides Test by End User

    9 Central & South America

    • 9.1 Central & South America Endocrine Peptides Test by Countries
      • 9.1.1 Central & South America Endocrine Peptides Test Sales by Countries
      • 9.1.2 Central & South America Endocrine Peptides Test Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Endocrine Peptides Test by Product
    • 9.3 Central & South America Endocrine Peptides Test by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Endocrine Peptides Test by Countries
      • 10.1.1 Middle East and Africa Endocrine Peptides Test Sales by Countries
      • 10.1.2 Middle East and Africa Endocrine Peptides Test Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Endocrine Peptides Test by Product
    • 10.3 Middle East and Africa Endocrine Peptides Test by End User

    11 Company Profiles

    • 11.1 Quest Diagnostics
      • 11.1.1 Quest Diagnostics Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Quest Diagnostics Endocrine Peptides Test Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Quest Diagnostics Endocrine Peptides Test Products Offered
      • 11.1.5 Quest Diagnostics Recent Development
    • 11.2 Siemens Healthcare
      • 11.2.1 Siemens Healthcare Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Siemens Healthcare Endocrine Peptides Test Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Siemens Healthcare Endocrine Peptides Test Products Offered
      • 11.2.5 Siemens Healthcare Recent Development
    • 11.3 Abbott Laboratories
      • 11.3.1 Abbott Laboratories Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Abbott Laboratories Endocrine Peptides Test Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Abbott Laboratories Endocrine Peptides Test Products Offered
      • 11.3.5 Abbott Laboratories Recent Development
    • 11.4 bioMerieux
      • 11.4.1 bioMerieux Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 bioMerieux Endocrine Peptides Test Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 bioMerieux Endocrine Peptides Test Products Offered
      • 11.4.5 bioMerieux Recent Development

    12 Future Forecast

    • 12.1 Endocrine Peptides Test Market Forecast by Regions
      • 12.1.1 Global Endocrine Peptides Test Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Endocrine Peptides Test Revenue Forecast by Regions 2019-2025
    • 12.2 Endocrine Peptides Test Market Forecast by Product
      • 12.2.1 Global Endocrine Peptides Test Sales Forecast by Product 2019-2025
      • 12.2.2 Global Endocrine Peptides Test Revenue Forecast by Product 2019-2025
    • 12.3 Endocrine Peptides Test Market Forecast by End User
    • 12.4 North America Endocrine Peptides Test Forecast
    • 12.5 Europe Endocrine Peptides Test Forecast
    • 12.6 Asia Pacific Endocrine Peptides Test Forecast
    • 12.7 Central & South America Endocrine Peptides Test Forecast
    • 12.8 Middle East and Africa Endocrine Peptides Test Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Endocrine Peptides Test Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Endocrine peptide test is used for the measurement of the level of c-peptide present in the blood. C-peptide and insulin are usually found in equivalent amounts. 
      The global Endocrine Peptides Test market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Endocrine Peptides Test market based on company, product type, end user and key regions.

      This report studies the global market size of Endocrine Peptides Test in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Endocrine Peptides Test in these regions.
      This research report categorizes the global Endocrine Peptides Test market by top players/brands, region, type and end user. This report also studies the global Endocrine Peptides Test market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Quest Diagnostics
      Siemens Healthcare
      Abbott Laboratories
      bioMerieux

      Market size by Product
      Estradiol (E2)
      Dehydroepiandrosterone Sulfate (DHEAS)
      Human Chorionic Gonadotropin (hCG)
      Progesterone, Luteinizing Hormone (LH)
      Thyroid Stimulating Hormone (TSH)
      Thyroid Prolactin
      Others
      Market size by End User
      Hospitals
      Physicians’ offices
      Commercial Laboratories
      Health Care Centers

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Endocrine Peptides Test market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Endocrine Peptides Test market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Endocrine Peptides Test companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Endocrine Peptides Test submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Endocrine Peptides Test are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Endocrine Peptides Test market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now